AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-19091012_ITM" title="Facts and information about ABILIFY Now Applicable to Maintenance Treatment of Bipolar Disorder: FDA Approves New Indication.">ABILIFY Now Applicable to Maintenance Treatment of Bipolar Disorder: FDA Approves New Indication.</a>

Close Set up an RSS feed that alerts you when new articles from Asia Africa Intelligence Wire are available.

Frequently asked questions about RSS feeds

ABILIFY Now Applicable to Maintenance Treatment of Bipolar Disorder: FDA Approves New Indication.

Asia Africa Intelligence Wire

| March 10, 2005 | COPYRIGHT 2005 Financial Times Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(From Japan Corporate News Network)

Byline: Dale Hug-Staff Writer, newsroom@japancorp.net

Bristrol-Myers Squibb (BMS) and Otsuka Pharmaceutical have jointly announced that the US Food and Drug Administration (FDA) approved an additional indication for ABILIFY (aripiprazole) Tablets and Oral Solution, atypical antipsychotics, as of March 1.

With this approval, ...

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more

For more facts and information, see all results